Convatec Group shares have logged a 29.0% gain over the past 5 years, which puts more focus on whether the current price lines up with the cash the business can generate. With the stock recently closing at £2.37, the question for you is how that market tag compares with what a detailed cash flow view suggests.

• A 29.0% return over 5 years means long term holders have seen steady value creation on paper. The key issue now is whether those gains are supported by the company's cash generation.

• Ongoing investment in Convatec's medical products and related operations can influence future margins and capital needs. This may shift the timing and level of cash flows that underpin any Discounted Cash Flow (DCF) estimate.

• If you'd rather focus on earnings, this one's for you. See why Convatec Group's 49.5x P/E tells a different valuation story .

The issue now is whether Convatec Group's recent share price, after that multi year climb and shorter term swings, is justified by the cash flows implied in a Discounted Cash Flow (DCF) view.

If you are weighing Convatec Group against other opportunities where cash generation really matters, a focused stock screen is a helpful second lens. You can start with 9 high quality undervalued stocks .

Is Convatec Group Still Cheap on Cash Flow?

The Discounted Cash Flow (DCF) approach here looks at the cash Convatec Group can return to shareholders over time and discounts it back to today. On the latest numbers, the business generated about US$209.3 million in free cash flow over the last twelve months, and analysts expect this to rise over the coming decade, which the model treats as a growing cash flow profile rather than a turnaround story.

Those higher projected free cash flows, when discounted and compared with the current £2.37 share price, put Convatec Group's estimated intrinsic value substantially above where the stock trades today. The recent news around Melrose and GKN Aerospace highlights how operational or regulatory events can quickly influence sentiment across the wider industrial and healthcare space, which may help explain why the price can still sit below the value implied by Convatec Group's cash generation. Find out what Convatec Group could be worth using our Discounted Cash Flow (DCF) estimate .

The Convatec Group Narrative: What Would Justify Today's Price?

Narratives pick up where that valuation gap leaves you by spelling out what would need to happen to Convatec Group's growth, margins and earnings for the shares to be worth materially more or materially less than today's price, and they sit on Simply Wall St's Community page. Each one turns Convatec Group's implied fair value into a specific, trackable argument about the business so you can see how the story holds up over time.